Astrocyte infiltration into injectable collagen-based hydrogels containing FGF-2 to treat spinal cord injury

Biomaterials

Volumn 34, Issue 14, 2013, Pages 3591-

  Macaya, Daniel J ^a,b   Hayakawa, Kazuhide ^c   Arai, Ken ^c   Spector, Myron ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chemotaxis; Collagen; Fibroblast growth factor; In vitro test; Nerve tissue engineering; Spinal cord injury

Indexed keywords

BIOCHEMISTRY; CELL CULTURE; FIBROBLASTS; GELS; HYDROGELS; NEURONS; PATIENT REHABILITATION; SCAFFOLDS (BIOLOGY); TISSUE;

CHEMOTAXIS; FIBROBLAST GROWTH FACTOR; IN-VITRO TESTS; NERVE TISSUE ENGINEERING; SPINAL CORD INJURIES (SCI);

COLLAGEN;

COLLAGEN; FIBROBLAST GROWTH FACTOR 2; GENIPIN; IRIDOID;

ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CELL INFILTRATION; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; CROSS LINKING; HYDROGEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD INJURY; ANIMAL; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; METHODOLOGY; NERVE REGENERATION; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TISSUE ENGINEERING;

RATTUS;

ANIMALS; ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; FIBROBLAST GROWTH FACTOR 2; HYDROGELS; IRIDOIDS; NERVE REGENERATION; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; TISSUE ENGINEERING;

EID: 84875250680     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.12.050     Document Type: Article

References (58)

1. National Spinal Cord Injury Statistical Center Spinal cord injury facts and figures at a glance February 2012, University of Alabama at Birmingham, Birmingham Alabama.
2. Rowland J.W., Hawryluk G.W., Kwon B., Fehlings M.G. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 2008, 25:E2.
3. Macaya D., Ng K.K., Spector M. Injectable collagen-genipin gel for the treatment of spinal cord injury: in vitro studies. Adv Funct Mater 2011, 21:4788-4797.
4. Suzuki H., Yamazaki M., Chiba K., Sawanishi H. Characteristic properties of genipin as an activator in neuronal nitric oxide synthase. J Health Sci 2007, 53:730-733.
5. Yamazaki M., Chiba K. Neurotrophic effects of genipin on neuro2a cells. J Health Sci 2005, 51:687-692.
6. Koo H.J., Lim K.H., Jung H.J., Park E.H. Anti-inflammatory evaluation of gardenia extract, geniposide and genipin. J Ethnopharmacol 2006, 103:496-500.
7. Kalman M. Glial reaction and reactive glia. Advances in molecular and cell biology 2003, 787-835. Elsevier. H. Leif (Ed.).
8. Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 2009, 32:638-647.
9. Robel S., Berninger B., Gotz M. The stem cell potential of glia: lessons from reactive gliosis. Nat Rev Neurosci 2011, 12:88-104.
10. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B., Sofroniew M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 2004, 24:2143-2155.
11. Sofroniew M.V. Reactive astrocytes in neural repair and protection. Neuroscientist 2005, 11:400-407.
12. Buffo A., Rolando C., Ceruti S. Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. Biochem Pharmacol 2010, 79:77-89.
13. Rolls A., Shechter R., Schwartz M. The bright side of the glial scar in cns repair. Nat Rev Neurosci 2009, 10:235-241.
14. Davies J.E., Proschel C., Zhang N., Noble M., Mayer-Proschel M., Davies S.J. Transplanted astrocytes derived from bmp- or ctnf-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. J Biol 2008, 7:24.
15. Davies S.J., Goucher D.R., Doller C., Silver J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 1999, 19:5810-5822.
16. Davies S.J., Fitch M.T., Memberg S.P., Hall A.K., Raisman G., Silver J. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 1997, 390:680-683.
17. Faber-Elman A., Solomon A., Abraham J.A., Marikovsky M., Schwartz M. Involvement of wound-associated factors in rat brain astrocyte migratory response to axonal injury: in vitro simulation. J Clin Invest 1996, 97:162-171.
18. Hou Y.J., Yu A.C., Garcia J.M., Aotaki-Keen A., Lee Y.L., Eng L.F., et al. Astrogliosis in culture. iv. effects of basic fibroblast growth factor. J Neurosci Res 1995, 40:359-370.
19. Zai L.J., Yoo S., Wrathall J.R. Increased growth factor expression and cell proliferation after contusive spinal cord injury. Brain Res 2005, 1052:147-155.
20. Bikfalvi A., Klein S., Pintucci G., Rifkin D.B. Biological roles of fibroblast growth factor-2. Endocr Rev 1997, 18:26-45.
21. Freudenberg U., Hermann A., Welzel P.B., Stirl K., Schwarz S.C., Grimmer M., et al. A star-peg-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases. Biomaterials 2009, 30:5049-5060.
22. Mahoney M.J., Anseth K.S. Contrasting effects of collagen and bFGF-2 on neural cell function in degradable synthetic peg hydrogels. J Biomed Mater Res A 2007, 81:269-278.
23. Bribian A., Barallobre M.J., Soussi-Yanicostas N., de Castro F. Anosmin-1 modulates the fgf-2-dependent migration of oligodendrocyte precursors in the developing optic nerve. Mol Cell Neurosci 2006, 33:2-14.
24. Yun Y.R., Won J.E., Jeon E., Lee S., Kang W., Jo H., et al. Fibroblast growth factors: biology, function, and application for tissue regeneration. J Tissue Eng 2010, 2010:218142.
25. Polikov V.S., Su E.C., Ball M.A., Hong J.S., Reichert W.M. Control protocol for robust in vitro glial scar formation around microwires: essential roles of bfgf and serum in gliosis. J Neurosci Methods 2009, 181:170-177.
26. Eclancher F., Kehrli P., Labourdette G., Sensenbrenner M. Basic fibroblast growth factor (bfgf) injection activates the glial reaction in the injured adult rat brain. Brain Res 1996, 737:201-214.
27. Goddard D.R., Berry M., Kirvell S.L., Butt A.M. Fibroblast growth factor-2 induces astroglial and microglial reactivity in vivo. J Anat 2002, 200:57-67.
28. Reilly J.F., Bair L., Kumari V. Heparan sulfate modifies the effects of basic fibroblast growth factor on glial reactivity. Brain Res 1997, 759:277-284.
29. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat Rev Neurosci 2004, 5:146-156.
30. Menon V.K., Landerholm T.E. Intralesion injection of basic fibroblast growth factor alters glial reactivity to neural trauma. Exp Neurol 1994, 129:142-154.
31. Baumann M.D., Kang C.E., Tator C.H., Shoichet M.S. Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury. Biomaterials 2010, 31:7631-7639.
32. Rabchevsky A.G., Fugaccia I., Turner A.F., Blades D.A., Mattson M.P., Scheff S.W. Basic fibroblast growth factor (bfgf) enhances functional recovery following severe spinal cord injury to the rat. Exp Neurol 2000, 164:280-291.
33. Lee T.T., Green B.A., Dietrich W.D., Yezierski R.P. Neuroprotective effects of basic fibroblast growth factor following spinal cord contusion injury in the rat. J Neurotrauma 1999, 16:347-356.
34. Jimenez Hamann M.C., Tator C.H., Shoichet M.S. Injectable intrathecal delivery system for localized administration of egf and fgf-2 to the injured rat spinal cord. Exp Neurol 2005, 194:106-119.
35. Teng Y.D., Mocchetti I., Taveira-DaSilva A.M., Gillis R.A., Wrathall J.R. Basic fibroblast growth factor increases long-term survival of spinal motor neurons and improves respiratory function after experimental spinal cord injury. J Neurosci 1999, 19:7037-7047.
36. Kang C.E., Tator C.H., Shoichet M.S. Poly(ethylene glycol) modification enhances penetration of fibroblast growth factor 2 to injured spinal cord tissue from an intrathecal delivery system. J Control Release 2010, 144:25-31.
37. Meilander N.J., Yu X., Ziats N.P., Bellamkonda R.V. Lipid-based microtubular drug delivery vehicles. J Control Release 2001, 71:141-152.
38. Jain A., Kim Y., McKeon R., Bellamkonda R. In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of bdnf after spinal cord injury. Biomaterials 2006, 27:497-504.
39. Lee H., McKeon R.J., Bellamkonda R.V. Sustained delivery of thermostabilized chabc enhances axonal sprouting and functional recovery after spinal cord injury. Proc Natl Acad Sci U S A 2010, 107:3340-3345.
40. Hayakawa K., Arai K., Lo E.H. Role of erk map kinase and crm1 in il-1beta-stimulated release of hmgb1 from cortical astrocytes. Glia 2010, 58:1007-1015.
41. Renault-Mihara F., Katoh H., Ikegami T., Iwanami A., Mukaino M., Yasuda A., et al. Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase-3 inhibition. EMBO Mol Med 2011, 3:682-696.
42. Norenberg M.D., Smith J., Marcillo A. The pathology of human spinal cord injury: defining the problems. J Neurotrauma 2004, 21:429-440.
43. Kitano A., Saika S., Yamanaka O., Ikeda K., Reinach P.S., Nakajima Y., et al. Genipin suppresses subconjunctival fibroblast migration, proliferation and myofibroblast transdifferentiation. Ophthalmic Res 2006, 38:355-360.
44. Kitano A., Saika S., Yamanaka O., Reinach P.S., Ikeda K., Okada Y., et al. Genipin suppression of fibrogenic behaviors of the alpha-tn4 lens epithelial cell line. J Cataract Refract Surg 2006, 32:1727-1735.
45. Vaccarino F.M., Fagel D.M., Ganat Y., Maragnoli M.E., Ment L.R., Ohkubo Y., et al. Astroglial cells in development, regeneration, and repair. Neuroscientist 2007, 13:173-185.
46. Zukor K.A., Kent D.T., Odelberg S.J. Meningeal cells and glia establish a permissive environment for axon regeneration after spinal cord injury in newts. Neural Dev 2011, 6:1.
47. Goldshmit Y., Sztal T.E., Jusuf P.R., Hall T.E., Nguyen-Chi M., Currie P.D. Fgf-dependent glial cell bridges facilitate spinal cord regeneration in zebrafish. J Neurosci 2012, 32:7477-7492.
48. White R.E., Rao M., Gensel J.C., McTigue D.M., Kaspar B.K., Jakeman L.B. Transforming growth factor alpha transforms astrocytes to a growth-supportive phenotype after spinal cord injury. J Neurosci 2011, 31:15173-15187.
49. White R.E., Yin F.Q., Jakeman L.B. Tgf-alpha increases astrocyte invasion and promotes axonal growth into the lesion following spinal cord injury in mice. Exp Neurol 2008, 214:10-24.
50. Nair A., Frederick T.J., Miller S.D. Astrocytes in multiple sclerosis: a product of their environment. Cell Mol Life Sci 2008, 65:2702-2720.
51. Parr A.M., Tator C.H. Intrathecal epidermal growth factor and fibroblast growth factor-2 exacerbate meningeal proliferative lesions associated with intrathecal catheters. Neurosurgery 2007, 60:926-933. [discussion-33].
52. Spyrou G.E., Naylor I.L. The effect of basic fibroblast growth factor on scarring. Br J Plast Surg 2002, 55:275-282.
53. Zittermann S.I., Issekutz A.C. Basic fibroblast growth factor (bfgf, fgf-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. Am J Pathol 2006, 168:835-846.
54. Rabchevsky A.G., Fugaccia I., Fletcher-Turner A., Blades D.A., Mattson M.P., Scheff S.W. Basic fibroblast growth factor (bfgf) enhances tissue sparing and functional recovery following moderate spinal cord injury. J Neurotrauma 1999, 16:817-830.
55. Gomez-Pinilla F., Lee J.W., Cotman C.W. Distribution of basic fibroblast growth factor in the developing rat brain. Neuroscience 1994, 61:911-923.
56. Ard M.D., Bunge R.P. Heparan sulfate proteoglycan and laminin immunoreactivity on cultured astrocytes: relationship to differentiation and neurite growth. J Neurosci 1988, 8:2844-2858.
57. Zhang Z., Coomans C., David G. Membrane heparan sulfate proteoglycan-supported fgf2-fgfr1 signaling: evidence in support of the " cooperative end structures" model. J Biol Chem 2001, 276:41921-41929.
58. Lichtenstein M.P., Madrigal J.L., Pujol A., Galea E. Jnk/erk/fak mediate promigratory actions of basic fibroblast growth factor in astrocytes via ccl2 and cox2. Neurosignals 2012, 20:86-102.